ACHE and Alzheimer disease: Taking this background into account, it has been established that a selective, reversible inhibition of BChE or dual reversible inhibitors of AChE and BChE could be crucial in the pathogenesis of middle to advanced stages of AD, in order to prevent a further decline in the cognitive and mental abilities while the decline of cholinergic neurons persists [14, 16, 17].